BANK OF MONTREAL /CAN/ - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 85 filers reported holding OVID THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 6.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$5,000
-73.7%
1,333
-82.4%
0.00%
Q4 2020$19,000
+58.3%
7,578
+284.3%
0.00%
Q3 2020$12,000
-55.6%
1,972
-42.3%
0.00%
Q2 2020$27,0003,417
+10922.6%
0.00%
Q2 2019$031
+416.7%
0.00%
Q1 2019$06
-96.8%
0.00%
Q4 2018$0
-100.0%
188
+106.6%
0.00%
Q3 2018$1,0000.0%91
-3.2%
0.00%
Q2 2018$1,000940.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TLS Advisors LLC 1,380,346$3,51618.08%
Madison Avenue Partners, LP 3,104,603$8,009,8761.72%
BVF INC/IL 6,851,051$17,675,7120.65%
CHI Advisors LLC 864,822$2,231,2410.59%
EcoR1 Capital, LLC 6,117,400$15,782,8920.51%
Rubric Capital Management LP 7,001,124$18,062,9000.47%
Artal Group S.A. 2,500,000$6,4500.38%
Tejara Capital Ltd 118,791$306,4810.16%
DCF Advisers, LLC 68,264$176,1200.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 827,580$2,135,1560.06%
View complete list of OVID THERAPEUTICS INC shareholders